Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro Sort descending
  • Site
  • Posizione
  • Divisione
  • Business
  • Area funzionale
  • Data di pubblicazione
Titolo di lavoro Sort descending Site Posizione Divisione Business Area funzionale Data di pubblicazione
(Senior) Clinical Development Medical Director - Rheumatology East Hanover USA Development Innovative Medicines Research & Development Mag 20, 2024
349145BR - Director, Channel Enablement and Optimization Governance East Hanover USA US Innovative Medicines Marketing Set 13, 2024
ABL - RLT Field Sales (USA) USA US Innovative Medicines I saldi Apr 30, 2024
Access & Reimbursement Manager NPS - Enterprise - Great Lakes - Remote Field Non-Sales (USA) USA US Innovative Medicines I saldi Ott 17, 2024
Access & Reimbursement Manager NPS - Enterprise - Rocky Mountains - Remote Field Non-Sales (USA) USA US Innovative Medicines I saldi Ott 17, 2024
Access and Reimbursement Manager, Immunology – Hartford, CT - Remote Hartford (Connecticut) USA US Innovative Medicines I saldi Ott 17, 2024
AD, Access & Reimbursement - Minneapolis - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Ott 17, 2024
AD, Market Access TA Strategy- Breast & Women's Cancer East Hanover USA US Innovative Medicines Market Access Ott 16, 2024
AD, Patient Support Center - Program Monitoring Arizona USA US Innovative Medicines Quality Ott 04, 2024
Allergy Territory Account Specialist - Baltimore, MD - Remote Field Sales (USA) USA US Innovative Medicines I saldi Ott 18, 2024
Allergy Territory Account Specialist - Chicago, IL (North) - Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 23, 2024
Allergy Territory Account Specialist - Chicago, IL (South) - Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 11, 2024
Allergy Territory Account Specialist - Los Angeles, CA (East) - Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 23, 2024
Allergy Territory Account Specialist – Pasadena, CA – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 08, 2024
Allergy Territory Account Specialist – Queens, NY – Remote Queens (New York) USA US Innovative Medicines I saldi Ott 15, 2024
Allergy- Territory Account Specialist – Akron, OH– Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 10, 2024
Allergy- Territory Account Specialist – Detroit, MI – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 30, 2024
Allergy- Territory Account Specialist – San Francisco, CA – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 27, 2024
Allergy-Territory Account Specialist – Ann Arbor, MI – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 10, 2024
Allergy-Territory Account Specialist – Flint, MI – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 10, 2024
Allergy-Territory Account Specialist – Fort Wayne, IN – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 25, 2024
Allergy-Territory Account Specialist – Green Bay, WI – Remote Field Sales (USA) USA US Innovative Medicines I saldi Ago 27, 2024
Allergy-Territory Account Specialist – Kansas City, MO – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 09, 2024
Allergy-Territory Account Specialist – Minneapolis, MN – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 09, 2024
Allergy-Territory Account Specialist – Portland, OR – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 08, 2024
Allergy-Territory Account Specialist – Seattle E, WA – Remote Field Sales (USA) USA US Innovative Medicines I saldi Ott 11, 2024
Allergy-Territory Account Specialist – Toldeo, OH – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 13, 2024
Allergy-Territory Account Specialist – Tucson, AZ – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 12, 2024
Allergy-Territory Account Specialist – Wichita, KS – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 24, 2024
Asset Strategy Lead – Automation Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Set 27, 2024
Asset Strategy Lead – Biologics Analysis Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Set 27, 2024
Associate Clinical Research Medical Director - Oncology RLT Remote Position (USA) USA Development Innovative Medicines Research & Development Ago 29, 2024
Associate Director / Director Biotherapeutics (Dual Posting) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Ago 08, 2024
Associate Director Commercial Analytics (Cardiovascular) Distant Employee - Distant Working Arrangement (DWA) (USA) USA US Innovative Medicines Marketing Ott 18, 2024
Associate Director, Access & Reimbursement Oncology - Remote - TX,OK, AR Field Non-Sales (USA) USA US Innovative Medicines Market Access Ott 16, 2024
Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Ott 17, 2024
Associate Director, Access & Reimbursement RLT, Seattle, WA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Lug 19, 2024
Associate Director, Clinical QA East Hanover USA Development Innovative Medicines Quality Set 24, 2024
Associate Director, Corporate Event Marketing Cambridge (USA) USA Corporate Affairs CTS Communications & Public Affairs Ott 16, 2024
Associate Director, Curriculum Design East Hanover USA US Innovative Medicines I saldi Ott 04, 2024
Associate Director, Data Privacy, Digital & AI East Hanover USA Ethics Risk & Compliance Corporate Proprietà legali e intellettuali e conformità Set 04, 2024
Associate Director, Digital Analytics - HQ based - East Hanover, NJ East Hanover USA US Innovative Medicines Marketing Ott 09, 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs Ott 08, 2024
Associate Director, Integrated Insights, New Products, Oncology East Hanover USA US Innovative Medicines Marketing Ott 17, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit e finanza Ott 17, 2024
Associate Director, Marketing Strategist - Immunology East Hanover USA US Innovative Medicines Marketing Ott 16, 2024
Associate Director, Non-Clinical Statistics Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Ott 11, 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Ott 08, 2024
Associate Director, Statistical Programming East Hanover USA Development Innovative Medicines Research & Development Set 19, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit e finanza Set 06, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia